Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 51
Immunomodulatory biomaterials against bacterial infections: Progress, challenges, and future perspectives
Shutao Zhang, Hongtao Yang, Minqi Wang, et al.
The Innovation (2023) Vol. 4, Iss. 6, pp. 100503-100503
Open Access | Times Cited: 49
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Tuberculosis vaccines and therapeutic drug: challenges and future directions
Yajing An, Rong-Xiang Ni, Zhuang Li, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
Laura Matarazzo, Paulo Bettencourt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
An Overview of the Use of Nanoparticles in Vaccine Development
Daniel Lozano, Vicente Larraga, María Vallet‐Regí, et al.
Nanomaterials (2023) Vol. 13, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 25
Facilitating the development of urgently required combination vaccines
William P. Hausdorff, Shabir A. Madhi, Gagandeep Kang, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e1059-e1067
Open Access | Times Cited: 9
PANDEMIC EPIDEMIOLOGY: A COMPREHENSIVE REVIEW OF COVID-19 LESSONS AND FUTURE HEALTHCARE PREPAREDNESS
Olufunke Omotayo, Muridzo Muonde, Tolulope O Olorunsogo, et al.
International Medical Science Research Journal (2024) Vol. 4, Iss. 1, pp. 89-107
Open Access | Times Cited: 8
Current progress in the development of prophylactic and therapeutic vaccines
Tingting Li, Ciying Qian, Ying Gu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 679-710
Open Access | Times Cited: 30
Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy
Xuanyi He, Jing Wang, Yuqing Tang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 18
A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, et al.
Environmental Research (2023) Vol. 236, pp. 116823-116823
Closed Access | Times Cited: 18
Microfluidic-based technologies for diagnosis, prevention, and treatment of COVID-19: recent advances and future directions
E. Alperay Tarim, Müge Anıl-İnevi, Ilayda Ozkan, et al.
Biomedical Microdevices (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 15
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective
S. Furkan Demirden, Ilgin Kimiz‐Gebologlu, Suphi Ş. Öncel
ACS Omega (2024)
Open Access | Times Cited: 6
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 5
A Rapid Human Vaccine Process Development Map Outlining Lessons Learnt During the Covid-19 Pandemic
Michael J. Francis
(2025)
Closed Access
A new vaccination approach for Salmonellosis employing a multi-epitope vaccine based on live microbial cell factory from Lactococcus lactis
Reyhaneh Sadat Moosavi-Kohnehsari, Mahnaz Jafari-Sohi, Tohid Piri-Gharaghie, et al.
Poultry Science (2025) Vol. 104, Iss. 2, pp. 104789-104789
Open Access
Chitosan immunomodulation: insights into mechanisms of action on immune cells and signaling pathways
Majed Ghattas, Garima Dwivedi, Anik Chevrier, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 896-909
Open Access
Comparative evaluation of protective efficacy of experimental inactivated vaccines against haemorrhagic septicaemia
Pankaj Dhakarwal, Manisha Medhi, D. Muthuchelvan, et al.
Brazilian Journal of Microbiology (2025)
Closed Access
Protective immunity induced by a novel P1 adhesin C-terminal anchored mRNA vaccine against Mycoplasma pneumoniae infection in BALB/c mice
Qilin Zeng, Peiyuan Sun, Weiwei Li, et al.
Microbiology Spectrum (2025)
Open Access
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Galectin-8 and GEL01 as Potential Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine against Bovine Alphaherpesvirus Type-1
Claudia Alejandra Kornuta, Juan Esteban Bidart, Ivana Soria, et al.
Virology (2025) Vol. 604, pp. 110402-110402
Closed Access
DNA Nanostructures‐Based In Situ Cancer Vaccines: Mechanisms and Applications
Bingyu Lin, Yanfei Liu, Qi‐Wen Chen, et al.
Small Methods (2025)
Open Access
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines
Dang-Khoa Vo, Kieu The Loan Trinh
Vaccines (2025) Vol. 13, Iss. 2, pp. 191-191
Open Access
The impact of COVID-19 on autoimmune diseases
Altijana Hromić-Jahjefendić, Abas Sezer, Irma Mahmuljin
Progress in molecular biology and translational science (2025)
Closed Access
Page 1 - Next Page

Scroll to top